Home › continued
 

Keywords :   


Tag: continued

MCAA Bookings Data reveals continued growth in 2014.

2015-05-06 14:31:08| Industrial Newsroom - All News for Today

According to data reported by MCAA members in various reports, 2014 bookings in process measurement and automation industry grew ~14.2%. Bookings continue upward trend that began following 2009's Great Recession. Over 5 years since, bookings are up 110%, and 2014 represents third highest growth rate of 5 previous periods at $3.9 billion. Total actual bookings reported by all members participating in bookings reports as of December 2014 was $5.5 billion.

Tags: data growth continued reveals

 

Cotton Campaign urges continued Uzbek action

2015-04-23 16:08:00| Daily apparel & textile news and comment - from just-style.com

A number of organisations have written to US Secretary of State John Kerry to urge continued action against the government of Uzbekistan over its forced labour record.

Tags: action continued campaign cotton

 
 

Continued High Levels of Transmission Investment Enhance the Grid, Benefit Customers

2015-04-22 19:36:00| Transmission & Distribution World

An updated report by the Edison Electric Institute finds that investor-owned electric utilities are continuing to make significant investments to build needed and beneficial transmission infrastructure Content Classification:  Curated read more

Tags: high levels customers continued

 

Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress

2015-04-21 14:30:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today reaffirmed its longstanding commitment to discovering and developing novel medicines in the global fight against infectious diseases, including infections caused by resistant bacteria and other pathogens. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-295-0928orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: treatment continued annual developing

 

Alnylam trial confirms continued effectiveness of RNAi drugs

2015-04-21 13:50:02| Biotech - Topix.net

Trial results released today suggest the lead drug by Alnylam Pharmaceuticals for a rare neurodegenerative disease continues to stop nerve damage after a year, confirming earlier results. The trial is the longest one yet to measure the neuropathic effects of the drug by Alnylam , called Patisiran.

Tags: trial continued drugs effectiveness

 

Sites : [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] next »